| Dr Cyril A Dalmon, MD | |
|
80 Mahalani St, Wailuku, HI 96793-2531 | |
| (808) 243-6000 | |
| Not Available |
| Full Name | Dr Cyril A Dalmon |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 80 Mahalani St, Wailuku, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487819579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | A102120 (California) | Secondary |
| 207W00000X | Ophthalmology | MD-18475 (Hawaii) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hawaii Permanente Medical Group Inc | 7618880667 | 541 |
News Archive
The latest drug regimens, vaccines and diagnostic tools under development to combat tuberculosis could have a potentially large impact on the disease once they become available, according to research findings published in the Aug. 3 early edition online of the Proceedings of the National Academy of Sciences.
Researchers around Andreas Bartels at the Werner Reichardt Centre for Integrative Neurosciences (CIN) and the Max Planck Institute for Biological Cybernetics in Tübingen, Germany used this phenomenon to decipher a key mechanism of the brain functions that contributes to conscious visual perception.
The GW Cancer Institute is in its second year of funding from the Susan G. Komen for the Cure to help increase the quality of survivorship care for D.C.-area breast cancer survivors.
SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.
› Verified 9 days ago
| Entity Name | Hawaii Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710945969 PECOS PAC ID: 7618880667 Enrollment ID: O20031106000625 |
News Archive
The latest drug regimens, vaccines and diagnostic tools under development to combat tuberculosis could have a potentially large impact on the disease once they become available, according to research findings published in the Aug. 3 early edition online of the Proceedings of the National Academy of Sciences.
Researchers around Andreas Bartels at the Werner Reichardt Centre for Integrative Neurosciences (CIN) and the Max Planck Institute for Biological Cybernetics in Tübingen, Germany used this phenomenon to decipher a key mechanism of the brain functions that contributes to conscious visual perception.
The GW Cancer Institute is in its second year of funding from the Susan G. Komen for the Cure to help increase the quality of survivorship care for D.C.-area breast cancer survivors.
SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cyril A Dalmon, MD 80 Mahalani St, Wailuku, HI 96793-2531 Ph: (808) 243-6000 | Dr Cyril A Dalmon, MD 80 Mahalani St, Wailuku, HI 96793-2531 Ph: (808) 243-6000 |
News Archive
The latest drug regimens, vaccines and diagnostic tools under development to combat tuberculosis could have a potentially large impact on the disease once they become available, according to research findings published in the Aug. 3 early edition online of the Proceedings of the National Academy of Sciences.
Researchers around Andreas Bartels at the Werner Reichardt Centre for Integrative Neurosciences (CIN) and the Max Planck Institute for Biological Cybernetics in Tübingen, Germany used this phenomenon to decipher a key mechanism of the brain functions that contributes to conscious visual perception.
The GW Cancer Institute is in its second year of funding from the Susan G. Komen for the Cure to help increase the quality of survivorship care for D.C.-area breast cancer survivors.
SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.
› Verified 9 days ago
Dr. Jivin Gerard Tantisira, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 450 Hookahi St, Wailuku, HI 96793 Phone: 808-877-3984 Fax: 808-871-6498 | |
Clifford Rhodes, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2180 Main St, Wailuku, HI 96793 Phone: 808-242-6464 Fax: 808-243-2321 | |
Andrew William Parlin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 450 Hookahi St, Wailuku, HI 96793 Phone: 808-377-3984 | |
Dr. Uma D Chaluvadi, MD, FRCS, FRCOPHTH. Ophthalmology Medicare: Medicare Enrolled Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-244-9056 | |
Dr. Gary A Edwards, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 450 Ho'okahi Street, Aloha Eye Clinic, Wailuku, HI 96793 Phone: 808-877-3984 Fax: 808-871-6498 | |
Dr. Bruce R. Taylor, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 80 Mahalani St, Wailuku, HI 96793 Phone: 808-243-6000 |